首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1263851篇
  免费   96953篇
  国内免费   1595篇
耳鼻咽喉   16375篇
儿科学   41154篇
妇产科学   35138篇
基础医学   189065篇
口腔科学   34876篇
临床医学   117850篇
内科学   247702篇
皮肤病学   27415篇
神经病学   102113篇
特种医学   47249篇
外国民族医学   265篇
外科学   179299篇
综合类   25721篇
现状与发展   3篇
一般理论   569篇
预防医学   104220篇
眼科学   28076篇
药学   92950篇
  6篇
中国医学   1966篇
肿瘤学   70387篇
  2018年   13757篇
  2017年   10562篇
  2016年   11529篇
  2015年   13292篇
  2014年   18314篇
  2013年   27879篇
  2012年   38164篇
  2011年   40661篇
  2010年   23422篇
  2009年   22591篇
  2008年   38326篇
  2007年   40966篇
  2006年   40486篇
  2005年   39587篇
  2004年   38004篇
  2003年   36288篇
  2002年   35187篇
  2001年   56171篇
  2000年   57136篇
  1999年   48024篇
  1998年   12546篇
  1997年   11370篇
  1996年   11778篇
  1995年   11881篇
  1994年   11088篇
  1993年   10378篇
  1992年   38317篇
  1991年   37842篇
  1990年   36621篇
  1989年   35422篇
  1988年   32789篇
  1987年   32117篇
  1986年   30634篇
  1985年   28906篇
  1984年   21985篇
  1983年   19203篇
  1982年   11352篇
  1981年   10294篇
  1979年   20961篇
  1978年   15384篇
  1977年   12755篇
  1976年   11828篇
  1975年   12807篇
  1974年   15588篇
  1973年   15359篇
  1972年   14532篇
  1971年   13575篇
  1970年   12783篇
  1969年   12078篇
  1968年   11239篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Aristodemou  E.  Retzepi  M.  Calciolari  E.  Donos  N. 《Clinical oral investigations》2022,26(8):5223-5235
Clinical Oral Investigations - To evaluate the effect of membrane occlusiveness and experimental diabetes on early and late healing following guided bone regeneration. A total of 30 Wistar rats...  相似文献   
4.
5.
Objective: Hepatocellular carcinoma (HCC) microenvironment has been recognized as a key contributor for cancer progression, metastasis, and drug resistance. The crosstalk between tumor cells, the vascular endothelial growth factor (VEGF), and the chemokine (C-C motif) ligand 2 (CCL2) signaling networks mediates immunoinhibitory impact and facilitates tumor angiogenesis. The current investigation aimed at exploring the potent anti-cancer activity of the newly designed nano-based anti-cancer therapy comprising anti-VEGF drug, avastin (AV), and CCR2 antagonist (CR) to counteract HCC and tracking its mode of action in vivo. Methods: The prepared AV, CR, and AVCR nanoprototypes were characterized by nanoscale characterization techniques in our previous work. Here, they are applied for unearthing their anti-cancer properties / mechanisms in hepatic cancer-induced rats via analyzing protein levels and genetic expression of the elements incorporated in the angiogenesis, apoptosis, and metastasis signalling pathways. Results: The present results revealed a significant down-regulation in the angiogenesis, survival and metastasis indices along with up-regulation in the pro-apoptotic mediators upon treatment of hepatic cancer-bearing rats with the novel synthesized nanomaterials when compared with the untreated counterparts. We showed across HCC model that anti-VEGF in combination with CCR2 antagonism therapy leads to sensitization and enhanced tumor response over anti-VEGF or CCR2 antagonism monotherapy, particularly in its nanoscale formulation. Conclusion: The present approach provides new mechanistic insights into the powerful anti-hepatic cancer advantage of the novel nanoprototypes which is correlated with modulating critical signal transduction pathways implicated in tumor microenviroment such as angiogenesis, apoptosis and metastasis. This research work presents a substantial foundation for future studies focused on prohibiting cancer progression and recovery by targeting tumor microenviroment.  相似文献   
6.
Whether the underlying mutations are homozygous, heterozygous, or co-inherited with other hemoglobinopathies, sickle cell disease is known to afflict the kidneys, leading to the clinical entity known as sickle cell nephropathy (SCN). Although common, SCN remains diagnostically elusive. Conventional studies performed in the context of renal disorders often fail to detect early stage SCN. This makes the quest for early diagnosis and treatment more challenging, and it increases the burden of chronic kidney disease-related morbidity among patients. Novel diagnostic tools have been employed to overcome this limitation. In this study, we discuss various biomarkers of SCN, including those employed in clinical practice and others recently identified in experimental settings, such as markers of vascular injury, endothelial dysfunction, tubulo-glomerular damage, and oxidative stress. These include kidney injury molecule-1, monocyte chemoattractant protein-1, N-acetyl-B-D-glucosaminidase, ceruloplasmin, orosomucoid, nephrin, and cation channels, among others. Furthermore, we explore the potential of novel biomarkers for refining diagnostic and therapeutic approaches and describe some obstacles that still need to be overcome. We highlight the importance of a collaborative approach to standardize the use of promising new biomarkers. Finally, we outline the limitations of conventional markers of renal damage as extensions of the pathogenic process occurring at the level of the organ and its functional subunits, with a discussion of the expected pattern of clinical and biochemical progression among patients with SCN.  相似文献   
7.
8.
9.
10.
Bulletin of Experimental Biology and Medicine - The psychopharmacological effects of a stimulator of functions of progenitor cells of the nervous tissue STAT3 inhibitor (STAT3 Inhibitor XIV, LLL12)...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号